Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
148 participants
INTERVENTIONAL
2021-05-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotic on Atopic Dermatitis in Infant
NCT05286047
Effectiveness of Probiotics in Relieving Allergic Rhinitis in Children
NCT06676111
the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic Rhinitis
NCT01116778
Oral Probiotics on the Microbiome and Lipidome in Acne Vulgaris
NCT04596748
Efficacy and Safety of L. Plantarum and P. Acidilactici in Children With Upper Respiratory Tract Infections
NCT05279534
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Placebo
A pack of powder without probiotics.
1 pack / day
Probiotics Lactobacillus salivarius AP-32
Probiotics Lactobacillus salivarius AP-32
A pack of powder with probiotics Lactobacillus salivarius AP-32
1 pack / day
Probiotics Bifidobacterium animalis subsp. lactis CP-9
Probiotics Bifidobacterium animalis subsp. lactis CP-9
A pack of powder with probiotics Bifidobacterium animalis subsp. lactis CP-9
1 pack / day
Probiotics Lactobacillus rhamnosus LGG
Probiotics Lactobacillus rhamnosus LGG
A pack of powder with probiotics Lactobacillus rhamnosus LGG
1 pack / day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
A pack of powder without probiotics.
1 pack / day
Probiotics Lactobacillus salivarius AP-32
A pack of powder with probiotics Lactobacillus salivarius AP-32
1 pack / day
Probiotics Bifidobacterium animalis subsp. lactis CP-9
A pack of powder with probiotics Bifidobacterium animalis subsp. lactis CP-9
1 pack / day
Probiotics Lactobacillus rhamnosus LGG
A pack of powder with probiotics Lactobacillus rhamnosus LGG
1 pack / day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Take medicine like immune inhibition, or steroid injection in two weeks
* Participate in another clinical research or immune therapy in one month
* Have severe disease
* Inappropriate for this trial judged by PI
1 Year
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Glac Biotech Co., Ltd
INDUSTRY
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ho-Chang Kuo
Attending Physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
XPRPG8L0021~22
Identifier Type: -
Identifier Source: org_study_id
NCT05337670
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.